PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Hereditary mutations in BRCA genes increase risk of rare lymphoma among women with breast cancer who received textured breast implants

Despite the withdrawal of these implants, many women have them and should be aware of the related risk

2025-06-13
(Press-News.org) (WASHINGTON, June 13, 2025) – Women with breast cancer who were also carriers of the BRCA1 or BRCA2 mutation and received textured breast implants as part of their reconstructive surgery after mastectomy were 16 times more likely to develop breast implant-associated anaplastic large cell lymphoma (BIA-ALCL), a rare T-cell lymphoma, compared with similar women without these genetic mutations, according to a study published today in Blood Advances.

“Our findings show that BRCA1 and BRCA2 mutations are a significant risk factor for developing this type of lymphoma, confirming earlier suggestions of a possible role. It’s possible that implant-associated lymphoma is yet another cancer that can arise because of these genetic mutations,” said lead researcher Paola Ghione, MD, a lymphoma specialist at Memorial Sloan Kettering Cancer Center (MSKCC). She adds that the analysis underscores the need for women to include their personal history of mastectomy and implants long after surviving breast cancer itself.

This is the first large study to look at whether the BIA-ALCL occurrence is higher among women who have a BRCA mutation, which is also responsible for the onset of breast cancer in 5-10% of cases. Carrying a harmful mutation in the BRCA 1 or BRCA 2 gene increases the risk of several cancers, including those of the breast, ovaries, pancreas, and skin.

Earlier studies had shown an association between textured implants and the development of BIA-ALCL, leading to their recall from the European and U.S. markets in 2019. BIA-ALCL is a type of T-cell lymphoma that arises near textured breast implants, either as a collection of fluid or mass. It usually develops seven to 10 years after women undergo mastectomy and reconstructive surgery with implants.

In 2023, the U.S. Food and Drug Administration (FDA) reported a total of 1,264 cases and 63 deaths related to BIA-ALCL. While textured breast implants were used in about 12% of reconstructive surgeries in the U.S., they were the go-to in Europe, used in up to 95% of surgeries. Breast implants are generally changed every 10 to 15 years, so there are many women who still have these implants in their bodies, Dr. Ghione explained.

“If we look at the absolute numbers [seen in this study], it’s still fairly rare, but the important thing to note is that when we look at women with this genetic predisposition, there is a big jump in the percentage with this lymphoma,” she said. Other factors, including the type of implant filling (saline or silicone), age at breast cancer surgery, and prior cancer treatments (radiation or chemotherapy), were not found to be associated with developing BIA-ALCL.

In this study, Dr. Ghione and her colleagues pulled from MSKCC’s unique cohort of over 3,000 women who had breast implants as part of their breast cancer treatment and are followed over time to assess for complications. Within this group, 520 women were tested for the BRCA genes. They compared the prevalence of BRCA1 or BRCA2 mutations, confirmed through testing, between women who did and did not develop BIA-ALCL after reconstruction with textured implants only; smooth surface devices are not thought to carry the risk of lymphoma, Dr. Ghione explained.

Women were followed for a median of 11.5 years. Of the 520 women with breast cancer tested for BRCA, 8.3%, or 43 patients were carriers of BRCA1 or BRCA2 mutations.  The age-adjusted rate of developing BIA-ALCL for women with BRCA1 or BRCA2 mutations was 16 times the rate of BIA-ALCL among women without the genetic mutation. The researchers also conducted a case-control study with 13 BIA-ALCL cases matched one to three with 39 controls, which showed that the frequency of BRCA1 or BRCA2 mutations in BIA-ALCL cases was significantly higher than that of the controls.

“The implants that are put in place now are theoretically safe; however, there are still a lot of women who are living with textured breast implants, so it’s important that women know what implants they have and talk with their doctor and remember to report this surgery as part of their medical history,” Dr. Ghione said, further advising women to ask about genetic testing, including for BRCA 1 or BRCA 2 mutations, especially if they were diagnosed or have family members diagnosed with breast cancer at younger ages.

Given the low risk of BIA-ALCL, the FDA does not recommend having implants removed unless women are having symptoms. Symptoms can include pain, lumps, swelling, or unexpected changes in breast shape. However, the researchers said the study’s findings should prompt women who have had reconstructive breast surgery because of breast cancer to have open discussions with their health care team about the type of breast implants they have and what steps they can take to minimize any risk. This is especially true if their plastic surgeon is suggesting it’s time to replace the implants. 

This study did not include women with the BRCA1 or BRCA2 mutations who underwent prophylactic surgery to prevent breast cancer.

Dr. Ghione and team will continue to follow these women, as well as others in the cohort that have had textured implants removed. This study is limited in that it is from a single institution, though it included a diverse population and a very long follow up.

This study was funded by the National Institutes of Health’s National Cancer Institute.

 

###

 

Blood Advances (bloodadvances.org) is an online, open-access journal publishing more peer-reviewed hematology research than any other academic journal worldwide. Blood Advances is part of the Blood journals portfolio (bloodjournals.org) from the American Society of Hematology (ASH) (hematology.org).
 
Claire Whetzel, 202-629-5085
cwhetzel@hematology.org

 

 

 

 

 

 

 

 

 

 

END



ELSE PRESS RELEASES FROM THIS DATE:

Improving resilience to tsunamis and earthquakes via predictions of waste disposal times

2025-06-13
Tsunamis and earthquakes pose devastating threats to coastal communities worldwide. However, beyond the immediate destructive power of these events, the negative impact of the disaster waste they produce is sometimes overlooked. For example, when the 2011 Great East Japan Earthquake struck, approximately 23 million tons of waste were generated, severely hindering post-disaster recovery processes. Similarly, the 2024 Noto Peninsula Earthquake produced 2.7 million tons of waste—equivalent to seven years of normal waste disposal. Thus, rapid processing of disaster waste is essential for restoring community functionality, making it a critical ...

Scientists extend facial expression analysis system to include bonobos

2025-06-13
Researchers have successfully adapted a standardized system for analyzing facial expressions to include bonobos, our closest living relatives alongside chimpanzees. The study, led by an international team of scientists from multiple institutions including Leipzig University and the Max Planck Institute for Evolutionary Anthropology, extends the Chimpanzee Facial Action Coding System (ChimpFACS) to another species closely related to humans and chimpanzees, bonobos. The research confirms that bonobos possess a repertoire of 28 distinct facial movements, including ...

SGLT2 inhibitor empagliflozin treatment stabilizes kidney function in patients who have had a heart attack

2025-06-13
Journal: Nature Cardiovascular Research – June 13 Online Issue Author: Deepak L. Bhatt, MD, MPH, MBA, Director of Mount Sinai Fuster Heart Hospital and the Dr. Valentin Fuster Professor of Cardiovascular Medicine at the Icahn School of Medicine at Mount Sinai Title: Secondary analysis of the EMPACT-MI Trial Reveals Cardiovascular-Kidney Efficacy and Safety of Empagliflozin After Acute Myocardial Infarction Bottom line of study: SGLT2 inhibitors have become a major drug used to treat diabetes, heart failure, and chronic kidney disease. However, there have been questions as to whether it is safe to use these drugs ...

City of Hope developed a foundational map of tumor cells for personalized brain cancer treatments

2025-06-13
LOS ANGELES — City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the U.S. with its National Medical Center named top 5 in the nation for cancer by U.S. News & World Report, co-led the first study to demonstrate that characterizing genetic material near chromosomes forecasts how mutated, cancer-causing genes reengineer DNA and alter the tumor microenvironment. The leading-edge brain cancer research provides foundational knowledge that one day will improve the practice of precision medicine and allow oncologists to deliver more personalized therapies to cancer patients. Tiny DNA molecules ...

Pangolins in Africa hunted for food rather than illicit scales trade – with meat ranked as ‘tastiest’

2025-06-13
Study suggests that appetite for bushmeat – rather than black market for scales to use in traditional Chinese medicine – may be driving West Africa’s illegal hunting of one of the world’s most threatened mammals.   Interviews with hundreds of hunters show pangolins overwhelmingly caught for food, with majority of scales thrown away. Survey work shows pangolin is considered the most palatable meat in the region. The vast majority of pangolin hunting in African ...

How solvents shape precision drug delivery

2025-06-13
Even the best products won’t meet expectations if they are packed poorly — packaging matters. The same goes for drug delivery. Osaka Metropolitan University researchers have uncovered the critical role played by solvents in how effectively drugs can be loaded into metal–organic frameworks (MOFs), a promising class of drug carriers. Their findings shed light on a previously overlooked part of the loading process, with the potential to boost the efficiency of how medications are delivered inside the body. To treat diseases effectively, it’s not just the medicine that counts — but also how that medicine is delivered into our ...

Swarm intelligence directs longhorn crazy ants to clear the road ahead for sisters carrying bulky food

2025-06-13
Among the tens of thousands of ant species, incredible ‘intelligent’ behaviors like crop culture, animal husbandry, surgery, ‘piracy’, social distancing, and complex architecture have evolved. Yet at first sight, the brain of an ant seems hardly capable of such feats: it is about the size of a poppy seed, with only 0.25m to 1m neurons, compared to 86bn for humans. Now, researchers from Israel and Switzerland have shown how ‘swarm intelligence’ resembling advance planning can nevertheless emerge from the concerted operation of many of ...

Vaccinated patients hospitalized with COVID-linked acute kidney injury less likely to need dialysis, and more likely to survive, after discharge

2025-06-13
Vaccinated patients hospitalized with COVID-19 who developed acute kidney injury had better outcomes than unvaccinated patients with the same condition, new research suggests. The study found vaccinated patients were less likely to stay on dialysis after discharge, and more likely to survive, than unvaccinated patients. Acute kidney injury, or AKI, is common among people infected with COVID-19, with rates running as high at 46%. It can lead to a mild decrease in kidney function or, if severe enough, to dialysis. The long-term renal and survival outcomes of these patients, however, has not been ...

What’s driving the rise of NLM wines?

2025-06-13
New research from Adelaide Business School at the University of Adelaide provides a framework for understanding the growing consumer interest in no, low and mid (NLM) alcohol wines. Dr Hannah Ford’s comprehensive scoping review, published in Journal of Marketing Management , suggests that consumer adoption of NLM wines is influenced by a range of factors, while wine businesses themselves play a pivotal role. “The global wine industry is evolving rapidly in response to growing health-conscious and moderation-driven drinking trends,” Dr Ford explains. “The review proposes that appeal to NLM wines is influenced ...

Koalas set to benefit from new genetic screening tool

2025-06-13
A University of Queensland-led project has developed a tool to standardise genetic testing of koala populations, providing a significant boost to conservation and recovery efforts. Dr Lyndal Hulse from UQ’s School of the Environment said the standardised koala genetic marker panel provides a consistent method for researchers nationwide to capture and share koala genetic variation, enabling improved collaboration and data integration across studies. “Koalas in the wild are under increasing pressure ...

LAST 30 PRESS RELEASES:

Two frontiers: Illinois experts combine forces to develop novel nanopore sensing platform

Biotechnology governance entreaties released, echoing legacy of 1975 recombinant DNA guidelines

Review of active distribution network reconfiguration: Past progress and future directions

Revealing the lives of planet-forming disks

What’s really in our food? A global look at food composition databases and the gaps we need to fix

Racial differences in tumor collagen structure may impact cancer prognosis

Museomics highlights the importance of scientific museum collections

Fossil corals point to possibly steeper sea level rise under a warming world

The quantum mechanics of chiral spin selectivity

Bodybuilding in ancient times: How the sea anemone got its back

Science and innovation for a sustainable future

Strange radio pulses detected coming from ice in Antarctica

Amazon trees under pressure: New study reveals how forest giants handle light and heat

Cell-depleting treatment in severe RMD: New data

Vasodilation in systemic sclerosis

New ideas in gout management

Risk factors for progression in spondyloarthritis

Patient experiences In JIA

Patient organizations: The partner by your side

Nurses: A critical role for people with RMD

Online information for patients needs guidance

The many ways that AI enters rheumatology

Pregnancy outcomes in autoinflammatory disease

The value of physical activity for people with RMD

First data from the EULAR RheumaFacts project

Research spotlight: Preventing stalling to improve CAR-T cells’ efficacy against tumors

c-Fos expression differentially acts in the healthy brain compared with Alzheimer’s disease

Computed tomography perfusion and angiography for death by neurologic criteria

New tool could help Florida homeowners weather flood risks, lower insurance costs

Researchers develop a rapid method for building vascular organoids

[Press-News.org] Hereditary mutations in BRCA genes increase risk of rare lymphoma among women with breast cancer who received textured breast implants
Despite the withdrawal of these implants, many women have them and should be aware of the related risk